| Date | Time | Source | Headline | Symbol | Company |
| 06/22/2011 | 12:39PM | Zacks | Bydureon Gains EU Approval - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/21/2011 | 7:02AM | Dow Jones News | Lilly, Amylin, Alkermes Diabetes Drug Gets EU Approval | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/21/2011 | 6:13AM | PR Newswire (US) | BYDUREON™ RECEIVES MARKETING AUTHORIZATION IN EUROPE | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/20/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/16/2011 | 11:12AM | Zacks | Eli Lilly Launches Tradjenta - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/13/2011 | 1:47PM | Dow Jones News | UPDATE: Forest Labs Discloses Icahn Attempt At Board Shakeup | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2011 | 12:11PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2011 | 10:30AM | Zacks | Favorable Ruling for Lilly - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2011 | 10:30AM | Zacks | Favorable Ruling for Lilly - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2011 | 6:03AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/08/2011 | 5:44PM | Dow Jones News | Lilly Wins Latest Round In Diabetes-Drug Feud With Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/08/2011 | 4:57PM | PR Newswire (US) | Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 12:32PM | Dow Jones News | PRESS RELEASE: Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 11:45AM | PR Newswire (US) | Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/01/2011 | 2:24PM | Zacks | Positive Data on Sanofi's Lyxumia - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/31/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Goldman Sachs 32nd Annual Global Healthcare Conference and Jefferies Global Life Sciences C | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/26/2011 | 4:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/26/2011 | 11:00AM | Zacks | Temporary Restraining Order for LLY - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/26/2011 | 10:13AM | Dow Jones News | Amylin Gets Temporary Order To Keep Lilly From Selling Rival's Drug | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/26/2011 | 6:13AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/26/2011 | 1:22AM | PR Newswire (US) | Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2011 | 5:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |